30 Mar 23
A company with a major marketed oncology product loses the Lead Clinical Safety physician, threatening defence of the label at EMA and FDA and further development plans.
tranScrip provided at short notice a highly experienced oncology drug safety physician, who assumed global safety leadership.
The development programme was able to continue and the label extensions were successfully negotiated with the regulatory agencies.
We have teams of life science and R&D experts to help achieve your goals and seize opportunities. Whatever your project requires, we have the people to meet your needs.